Risk factors for peritoneal dialysis-related peritonitis: Can we reduce the incidence and improve patient selection?

被引:63
作者
Kotsanas, Despina
Polkinghorne, Kevan R.
Korman, Tony M.
Atkins, Robert C.
Brown, Fiona
机构
[1] So Hlth Monash Med Ctr, Dept Infect Dis, Clayton, Vic 3168, Australia
[2] So Hlth Monash Med Ctr, Dept Nephrol, Clayton, Vic 3168, Australia
[3] Queen Elizabeth Hosp, Australian & New Zealand Dialysis & Transplant Re, Woodville, SA 5011, Australia
关键词
cohort study; microbiology; peritoneal dialysis; peritonitis; risk factor;
D O I
10.1111/j.1440-1797.2006.00756.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: Peritonitis is a serious complication of peritoneal dialysis (PD) and a major cause of hospitalization, catheter loss, transfer to haemodialysis and death. Thus, it is important to identify risk factors for PD-related peritonitis in order to reduce the incidence and improve patient selection. Methods: This study is a prospective cohort review (1992-2003) with data consisting of 12 844 patient months, 506 PD patients and 623 episodes of peritonitis. Comorbidities and patient demographics were provided by the Australian and New Zealand Dialysis and Transplant Registry and these were merged with the hospital combined clinical and microbiology laboratory peritonitis database. Results: Variables identified to be associated with an increased likelihood of peritonitis were: age (every 10 years; OR, 1.26; 95% CI, 1.07-1.48), gender (female; OR, 1.91; 95% CI, 1.2-3.01), current smoker at entry to dialysis (OR, 1.71; 95% CI, 1.04-2.82) and the pre twin bag connection system (OR, 2.07; 95% CI, 1.22-3.52). Conclusion: Increasing age, female gender and smoking increased the risk of peritonitis. Identifying these risk factors will assist in the selection, training and monitoring of our PD population.
引用
收藏
页码:239 / 245
页数:7
相关论文
共 26 条
  • [1] *ANZDATA, 2003, ANZDATA REG DAT DAT
  • [2] A randomized trial of Staphylococcus aureus prophylaxis in peritoneal dialysis patients: Mupirocin calcium ointment 2% applied to the exit site versus cyclic oral rifampin
    Bernardini, J
    Piraino, B
    Holley, J
    Johnston, JR
    Lutes, R
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 1996, 27 (05) : 695 - 700
  • [3] BORDES A, 1995, PERITON DIALYSIS INT, V15, P275
  • [4] Chow KM, 2005, PERITON DIALYSIS INT, V25, P374
  • [5] DALY C, 2003, COCHRANE LIB
  • [6] Do the Y-set and double-bag systems reduce the incidence of CAPD peritonitis? A systematic review of randomized controlled trails
    Daly, CD
    Campbell, MK
    MacLeod, AM
    Cody, DJ
    Vale, LD
    Grant, AM
    Donaldson, C
    Wallace, SA
    Lawrence, PD
    Khan, IH
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2001, 16 (02) : 341 - 347
  • [7] CONTROLLED TRIAL OF A Y-SET DIALYSIS DELIVERY SYSTEM TO PREVENT PERITONITIS IN PATIENTS RECEIVING CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS
    DRYDEN, MS
    MCCANN, M
    WING, AJ
    PHILLIPS, I
    [J]. JOURNAL OF HOSPITAL INFECTION, 1992, 20 (03) : 185 - 192
  • [8] Fernandez Maria A, 2004, Adv Perit Dial, V20, P128
  • [9] Forbes A, 2001, AUSTRALASIAN EPIDEMI, V8, P13
  • [10] Fried L, 2000, TEXTBOOK OF PERITONEAL DIALYSIS, 2ND EDITION, P545